Comparative Pharmacology
Head-to-head clinical analysis: NULYTELY versus POLYETHYLENE GLYCOL 3350.
Peer-Reviewed Evidence
Head-to-head clinical analysis: NULYTELY versus POLYETHYLENE GLYCOL 3350.
NULYTELY vs POLYETHYLENE GLYCOL 3350
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Polyethylene glycol (PEG) 3350 is an osmotic agent that induces diarrhea by drawing water into the gastrointestinal tract, thereby cleansing the bowel. Sodium sulfate and electrolytes (sodium, potassium, bicarbonate) are added to prevent fluid and electrolyte shifts.
Osmotic laxative. Polyethylene glycol 3350 is a non-absorbable polymer that retains water in the colon via hydrogen bonding, increasing stool water content and stimulating defecation.
4 liters orally of the reconstituted solution as a single dose for colonoscopy preparation, typically administered in divided doses (e.g., 240 mL every 10 minutes) until rectal effluent is clear. Alternatively, a split-dose regimen: half the solution evening before, half on the day of procedure.
17 g (1 capful or packet) dissolved in 4–8 oz (120–240 mL) water, administered orally once daily for constipation; for colonoscopy preparation, 240 g (4 L of solution) ingested at 240 mL every 10–15 minutes.
None Documented
None Documented
Not applicable; NULYTELY is not systemically absorbed in significant amounts, so a terminal elimination half-life is not defined. The drug acts locally in the gastrointestinal tract.
Terminal elimination half-life is 1-2 hours in patients with normal renal function; prolonged in renal impairment, but clinical impact minimal due to primarily fecal elimination.
NULYTELY (polyethylene glycol 3350) is minimally absorbed systemically (<0.06%). The primary route of elimination is fecal excretion of the intact polymer. Renal excretion is negligible (<0.02%).
Renal: approximately 20% excreted unchanged; Fecal: approximately 80% eliminated unchanged in feces.
Category C
Category C
Osmotic Laxative
Osmotic Laxative